To confirm our hypothesis that BRD4 recruited IRF1 to mediated PD‐L1 expression after radiation and cisplatin treatment, we started with validating the interaction between BRD4 and IRF1 in NSCLC by the co‐IP experiments (Figure 3D,E). The gene discussed is IRF1; the disease is non-small cell lung carcinoma.